Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.
G FabbrociniClaudio MarascaMatteo MegnaK Perisnull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
HIDRAdisk appears as a complete and informative tool which can easily measure the global burden of HS, guiding treatment choice and evaluating its efficacy.
Keyphrases
- hidradenitis suppurativa
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- mental health
- metabolic syndrome
- patient reported outcomes
- risk factors
- adipose tissue
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- combination therapy
- disease activity